SCHEDULE 13G/A: John A. Kryzanowski Discloses 6.27% Passive Stake in Synlogic, Inc.
Beneficial Ownership Report
John A. Kryzanowski has filed an amended Schedule 13G, reporting a passive beneficial ownership of 6.27% of Synlogic, Inc.'s common stock as of December 31, 2024.
Summary
- John A. Kryzanowski beneficially owns 733,412 shares of Synlogic, Inc. common stock.
- This ownership represents 6.27% of the company's total outstanding common stock.
- The reported stake comprises 592,567 shares of common stock and an additional 140,845 shares underlying warrants held by Mr. Kryzanowski.
- The percentage of ownership is calculated based on 11,696,109 shares of Synlogic, Inc. common stock outstanding as of November 5, 2024, as previously reported in the company's Form 10-Q for the quarterly period ended September 30, 2024.
- Mr. Kryzanowski holds sole voting power and sole dispositive power over all 733,412 beneficially owned shares.
- This filing is an Amendment No. 3 to a previous Schedule 13G, indicating an update to a prior ownership disclosure.
- The securities are certified as not being acquired or held for the purpose of changing or influencing the control of Synlogic, Inc., consistent with a passive investment.
Sentiment
Score: 6
Explanation: The filing is neutral in tone, but the disclosure of a significant individual stake (over 5%) can be interpreted as a positive signal of investor confidence, slightly elevating the sentiment above neutral.
Positives
- The disclosure of a significant individual stake (over 5%) by John A. Kryzanowski may signal investor confidence in Synlogic, Inc.
- Mr. Kryzanowski holds sole voting and dispositive power over his shares, indicating direct control over his investment decisions.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership and does not provide specific insights into broader industry trends or competitive landscape beyond the fact that an individual investor holds a significant stake in a biotechnology company (Synlogic, Inc. is known for synthetic biology).
Stakeholder Impact
- Shareholders: The disclosure of a significant individual stake provides transparency regarding the ownership structure and may influence investor perception and confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 2024-09-30 | End of the quarterly period for which Synlogic, Inc. reported outstanding shares on Form 10-Q. |
| 2024-11-05 | Date as of which Synlogic, Inc. reported 11,696,109 shares of common stock outstanding in its Form 10-Q, used for percentage calculation. |
| 2024-12-31 | Date of event which requires the filing of this statement, reflecting the beneficial ownership position at year-end. |
| 2025-02-25 | Date of filing of this Schedule 13G Amendment No. 3. |
Keywords
Synlogic Inc., John A. Kryzanowski, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Equity Stake, Warrants, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.